跳至主要内容
临床试验/NCT01477944
NCT01477944已完成不适用

Pattern of Statins Use in Catalonia

AstraZeneca0 个研究点目标入组 180,723 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
180,723
主要终点
Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.

研究概览

简要总结

To describe the new statins prescription pattern in Catalonia (getting their first prescription for any statin, or receiving a change in their statin treatment including switching, changing in doses or adding ezetimibe/fibrates) since September 2009.

详细描述

Pattern of statins use in Catalonia.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Description of detailed clinical treatment in terms of duration of treatment, doses, drug switches and add-on therapy, in patients with hypercholesterolemia and on treatment with statins from the index date.

时间窗: From 1st September 2009 to 30th August 2010

Type of prescriber

时间窗: From 1st September 2009 to 30th August 2010

Number of patient, whom the drug was prescribed by the specified type of prescriber (specialist, general practitioner, etc.)

Date of change from previous statin to new.

时间窗: From 1st September 2009 to 30th August 2010

次要结局

  • Description of demographic data including: Sex, Age, Height (cm), Weight (kg), Smoking habits (packs-years), Alcohol consume habits (units/week), active worker or retired, Pregnancy.(From 1st September 2009 to 30th August 2010)
  • Total cholesterol(From 1st September 2009 to 30th August 2010)
  • Low Density Lipoprotein (LDL) cholesterol concentration(From 1st September 2009 to 30th August 2010)
  • High Density Lipoproteins (HDL) cholesterol concentration(From 1st September 2009 to 30th August 2010)
  • Triglicerides (TG) concentration(From 1st September 2009 to 30th August 2010)
  • Aspartate Aminotransferase (ASAT) concentration(From 1st September 2009 to 30th August 2010)
  • Serum Glucose concentration(From 1st September 2009 to 30th August 2010)
  • Serum Creatin Kinase (CK) concentration(From 1st September 2009 to 30th August 2010)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

相似试验